Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial
Authors:
- A. BowmanABA. Bowman
- T. PerrenTPT. Perren
- K. J. QuinnKQK. J. Quinn
Open Access
- 1 June 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (6) , 569-573
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Protective effects of glutathione on cisplatin neurotoxicity in ratsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- High‐dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urineEuropean Journal of Clinical Investigation, 1991
- Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancerCancer Chemotherapy and Pharmacology, 1990
- Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drugChemico-Biological Interactions, 1989
- Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival durationCancer, 1988
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Tests for Linear Trends in Proportions and Frequencies1955
- Some Methods for Strengthening the Common χ 2 TestsBiometrics, 1954